Abstract
Chromobacterium violaceum is an emerging environmental pathogen that causes life-threatening infection in humans and animals. In October 2017, a Bangladeshi farmer was hospitalized with high-grade fever due to an agricultural injury-related wound infection. Bacteriological and 16S rRNA gene investigation detected C. violaceum in the wound discharge. The patient recovered successfully after a combination treatment with meropenem and ciprofloxacin, followed by prolonged medication to avoid recurrence. We strongly propose to incorporate C. violaceum in the differential diagnosis of wound and skin infections occurring in tropical and subtropical regions, especially when the injury was exposed to soil or sluggish water.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Anti-Bacterial Agents / therapeutic use
-
Bacterial Typing Techniques
-
Chromobacterium / classification
-
Chromobacterium / drug effects
-
Chromobacterium / genetics
-
Chromobacterium / pathogenicity*
-
Ciprofloxacin / therapeutic use*
-
Farmers
-
Humans
-
Male
-
Meropenem / therapeutic use*
-
Microbial Sensitivity Tests
-
Neisseriaceae Infections / drug therapy*
-
Neisseriaceae Infections / microbiology
-
Neisseriaceae Infections / pathology
-
Phylogeny
-
RNA, Ribosomal, 16S / genetics
-
Sepsis / drug therapy*
-
Sepsis / microbiology
-
Sepsis / pathology
-
Treatment Outcome
-
Wound Infection / drug therapy*
-
Wound Infection / microbiology
-
Wound Infection / pathology
Substances
-
Anti-Bacterial Agents
-
RNA, Ribosomal, 16S
-
Ciprofloxacin
-
Meropenem
Supplementary concepts
-
Chromobacterium violaceum